Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Lipid Absorption
Bioavailability Enhancement: Drug Permeability Enhancement
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 4, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Michael C Honigberg1,2,3,4, Pradeep Natarajan1,2,3,4
1Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston.
No abstract available in PubMed .